McCloskey, E. V.
Fitzpatrick, L. A.
Hu, M.-Y.
Williams, G.
Kanis, J. A.
Funding for this research was provided by:
University of Sheffield
Article History
Received: 8 August 2018
Accepted: 20 January 2019
First Online: 5 February 2019
Compliance with ethical standards
:
: Dr. McCloskey reports that he and/or his institution has received consultancy fees, and/or research funding, and/or honoraria from AgNovos, Alliance for Better Bone Health, Amgen, Consilient, Fresenius Kabi, GE Lunar, GSK, Hologic, Internis, Lilly, Merck, Novartis, ONO, Pfizer, Radius Health, Inc., Redx Oncology, Roche, Servier, UCB, and Wyeth. Dr. Kanis reports grants from Amgen and Lilly, nonfinancial support from Medimaps and other support from AgNovos. Dr. Kanis is the architect of FRAX but has no financial interest in it. Drs. Fitzpatrick, Williams, and Hu are employees of and hold stock in Radius Health, Inc.